selegiline has been researched along with Pituitary ACTH Hypersecretion in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| da Silva Mello, FP; da Silva, CC; de Carvalho, GLC; de Faria Valle, S; de Moura Martins, FS; Furtado, PV; Machado, L; Meirelles, L; Neto, WS; Pöppl, ÁG | 1 |
1 trial(s) available for selegiline and Pituitary ACTH Hypersecretion
| Article | Year |
|---|---|
Assessment of selegiline and trilostane combined therapy efficacy for canine pituitary-dependent hypercortisolism treatment: A pilot randomized clinical trial.
Topics: Adrenocorticotropic Hormone; Animals; Cushing Syndrome; Dihydrotestosterone; Dog Diseases; Dogs; Hydrocortisone; Pilot Projects; Pituitary ACTH Hypersecretion; Selegiline | 2022 |